Pujitha Wickramasinghe
Overview
Explore the profile of Pujitha Wickramasinghe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dabare P, Wickramasinghe P, Waidyatilaka I, Devi S, de Lanerolle Dias M, Wickremasinghe R, et al.
Eur J Clin Nutr
. 2025 Feb;
PMID: 39966666
Background And Objective: Valid and cost-effective approaches are essential to assess physical activity and sedentary behaviours in individuals of all ages. This study aimed to validate a physical activity recall...
2.
Nusurupia J, Germana L, Wickramasinghe P, Tang H, Munambah N, Hossain M, et al.
Child Care Health Dev
. 2024 Nov;
50(6):e70008.
PMID: 39564734
Background: Insufficient physical activity, excessive screen time and short sleep duration among young children are global public health concerns; however, data on prevalence of meeting World Health Organisation 24-h movement...
3.
Fernando L, Kastner R, Wickramasinghe P, Fernando A, Gunasekera D, Nguyen V, et al.
PLoS Negl Trop Dis
. 2024 Aug;
18(8):e0012376.
PMID: 39173075
Background: Outbreaks of dengue can overburden hospital systems, drastically reducing capacity for other care. The 2017 dengue serotype 2 (DENV-2) outbreak in Sri Lanka coincided with vaccination in an ongoing...
4.
Athapathu A, Wijayawardhana S, Meegoda J, Gunaratne S, Somathilaka M, Chang K, et al.
SAGE Open Med Case Rep
. 2023 Dec;
11:2050313X231220826.
PMID: 38149118
Congenital mesoblastic nephroma is considered a tumour with favourable clinical behaviour with only few reported cases of metastases. We report an infant who underwent complete resection and later developed pulmonary...
5.
Dabare P, Wickramasinghe P, Waidyatilaka I, Devi S, Kurpad A, Samaranayake D, et al.
Nutrients
. 2023 Feb;
15(4).
PMID: 36839264
This study aimed to develop a regression equation to predict physical activity energy expenditure (PAEE) using accelerometry. Children aged 11-13 years were recruited and randomly assigned to validation ( =...
6.
Loo B, Okely A, Taylor R, Novotny R, Wickramasinghe P, Muller-Riemenschneider F, et al.
Lancet Reg Health West Pac
. 2023 Feb;
32:100641.
PMID: 36785856
Background: Early childhood is a vital period for development and growth. Promoting beneficial lifestyle behaviours in early childhood can help optimise children's health, development and learning, shape their behaviours in...
7.
Dissanayake R, Samarasinghe N, Waidyanatha S, Pathirana S, Neththikumara N, Dissanayake V, et al.
BMC Pediatr
. 2022 Jun;
22(1):344.
PMID: 35705926
Background: Iron overload (IO) is a complication in transfusion dependent beta thalassaemia (TDT). Pathogenic variants in genes involving iron metabolism may confer increased risk of IO. The objective of this...
8.
Okely T, Reilly J, Tremblay M, Kariippanon K, Draper C, Hamdouchi A, et al.
BMJ Open
. 2021 Oct;
11(10):e049267.
PMID: 34697112
Introduction: 24-hour movement behaviours (physical activity, sedentary behaviour and sleep) during the early years are associated with health and developmental outcomes, prompting the WHO to develop Global guidelines for physical...
9.
Rivera L, Biswal S, Saez-Llorens X, Reynales H, Lopez-Medina E, Borja-Tabora C, et al.
Clin Infect Dis
. 2021 Oct;
75(1):107-117.
PMID: 34606595
Background: Takeda's live attenuated tetravalent dengue vaccine candidate (TAK-003) is under evaluation in a long-term clinical trial across 8 dengue-endemic countries. Previously, we have reported its efficacy and safety in...
10.
Ranawaka R, Jayamanne C, Dayasiri K, Samaranayake D, Sandakelum U, Hathagoda W, et al.
J Trop Med
. 2021 Jun;
2021:8842799.
PMID: 34122560
Pathogenesis of dengue haemorrhagic fever is not fully understood, but it is thought that there is antibody enhancement during the secondary infection, which causes severe dengue haemorrhagic fever (DHF). Therefore,...